Cullinan Therapeutics Inc (CGEM)

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	6.62%57.25	53.70	55.26	55.60	75.80
Research and Development	5.49%44.44	42.12	42.95	41.97	61.03
Operating Income/Loss	6.62%-57.25	-53.70	-55.26	-55.60	-75.80
Net Income/Loss	8.14%-53.70	-49.66	-50.71	-50.61	-70.06